In this study, we showed that miR-203 inhibited ovarian primary tumor growth and tumor metastasis by targeting survivin and attenuating the TGFβ pathway in an orthotopic ovarian cancer mouse model. The gene discussed is TGFB1; the disease is ovarian carcinoma.